Stop Acting So Surprised That the Dow Just Hit 23,000
Logging record highs is par for the course over the Dow's 121-year history.
3 Reasons the Best Is Yet to Come for Netflix Investors
Growing through a rate hike, paid international subscribers surpassing domestic accounts, and the leverage behind the rate hike should keep the good times going for Netflix stock.
5 Oil Stocks Built to Thrive at $50 Crude
Crude has crept back above $50 a barrel in recent weeks, which is a boon for these oil stocks.
Earnings beat expectations, but not all of the news is good for Cree today.
This shale driller has displayed a breathtaking improvement in just the past year.
The long, storied history of the financial services giant is hard to match, but there are a few stocks facing similar transitions.
On another record-setting day for the market, these stocks stood out. Find out why.
Even as the market climbed, these stocks lagged behind. Find out why.
Snapchat's parent company strikes a deal with Discovery's Eurosport to break down February's Winter Olympic Games. It's hard to decide who needs the other more at this point.
The specialist in mobile-device management software is down after posting underwhelming results and replacing its CEO.
Apple's latest chip is incredible, but this Fool thinks manufacturing technology snags held it back from reaching its true potential.
Both Ubisoft's and Take-Two's stock prices have soared in recent years. But only one can be the better buy.
Mexican beer expansion isn’t the only factor behind the company’s strong quarterly results.
The social network is still betting big on hardware.
Industry Focus tackles the controversy surrounding the sports apparel giant as shady practices come to light.
The public doesn't want to pay the higher costs associated with the more humane care.
Cloud computing, artificial intelligence, and new mainframe systems helped Big Blue put together a solid third-quarter report.
Canadian Pacific reported improving operating metrics, better-than-expected results, and increased guidance. That's a pretty killer combo.
The company says it will pursue higher volumes as competitors continue to lower fares.
The website development platform has been hit with the accusation of being a get-rich-quick scheme.
One is the "Priceline of China," another is solving HR problems, and the third specializes in drones.
CP earnings call for the period ending September 30, 2017.
The biopharma's lead drug candidate has strong potential based on a sneak peek at midstage trial data.